Kwangdong Pharmaceutical faces controversy over high-priced sales and improper advertising of Chimhyang pills: 'Manufacturing and quality control costs should be considered'
Predicted impact: Low· Actual: −6.7% vs sector, volume 1.1× normal (5 trading days)
Controversy over pricing and advertising; no fine, ruling, or size disclosed yet.